Additionally, Ioannou et al. confirmed D1 as the immunodominant epitope of β2GP1 in animal models of aPL-induced thrombosis, as treatment of recombinant D1 peptide protected C57BL/6 mice from human aPL-induced pathology9. Here, APOH is linked to deep vein thrombosis.